Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Nov 26;13:7281. doi: 10.1038/s41467-022-34871-9

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 5 — a IB analysis of C4-2 cells treated with TNFα, IL-6 and IFN-γ for the indicated duration of time. b IB analysis of C4-2 cells stimulated with TNFα with or without MG132 treatment for the indicated duration of time. c IB analysis of C4-2 cells transfected with scramble or P50, P52, or P65 oligonucleotides with or without TNFα treatment. d IB analysis of C4-2 cells transfected with scramble or IKKβ and IKKα oligonucleotides with or without TNFα treatment. e IB analysis of the WCL from WT and IKKβ KD C4-2 cells with or without TNFα treatment and anti-ARID1A immunoprecipitates as indicated. f IB analyses of the WCL and anti-ARID1A immunoprecipitates of C4-2 cells. g IB analysis of nuclear extracts from C4-2 cells after gel-filtration fractionation. Cells were treated with 20 ng/ml TNFα for 30 min before harvesting. h IB analysis of the indicated proteins in C4-2 control and IKKβ KD cells with or without IKKβ-WT, IKKβ-SA or IKKβ-SD overexpression. i IB analysis of C4-2 cells treated with IL-1β or c-GAMP for the indicated duration of time. All experiments were repeated three times independently with similar results; data from one representative experiment are shown. Source data are provided as a Source Data file.